The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
Progression from asymptomatic smoldering multiple myeloma (SMM) to symptomatic Multiple Myeloma occurs at different rates in different patients. Here, the authors report fewer NRAS and FAM46C mutations and adverse translocations in SMM compared to MM, while KRAS mutations are associated with a short...
Guardado en:
Autores principales: | Eileen M. Boyle, Shayu Deshpande, Ruslana Tytarenko, Cody Ashby, Yan Wang, Michael A. Bauer, Sarah K. Johnson, Christopher P. Wardell, Sharmilan Thanendrarajan, Maurizio Zangari, Thierry Facon, Charles Dumontet, Bart Barlogie, Arnaldo Arbini, Even H. Rustad, Francesco Maura, Ola Landgren, Fenghuang Zhan, Frits van Rhee, Carolina Schinke, Faith E. Davies, Gareth J. Morgan, Brian A. Walker |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/190cc8a591d94b4a813749741597a52e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genomic patterns of progression in smoldering multiple myeloma
por: Niccolò Bolli, et al.
Publicado: (2018) -
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
por: L. Rasche, et al.
Publicado: (2017) -
Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions
por: Blum A, et al.
Publicado: (2018) -
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosis
por: Alissa Visram, et al.
Publicado: (2021) -
Timing the initiation of multiple myeloma
por: Even H. Rustad, et al.
Publicado: (2020)